SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-006854
Filing Date
2015-10-19
Accepted
2015-10-19 17:15:31
Documents
1
Period of Report
2015-10-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4327
  Complete submission text file 0000899243-15-006854.txt   5919
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ARCA BIOPHARMA, INC. 11080 CIRCLEPOINT RD, STE 140 WESTMINSTER CO 80020
Business Address
Keuer Thomas A (Reporting) CIK: 0001290482 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 151164918